J&J to scout early-stage deals in 4 biotech hotspots

Johnson & Johnson never has made much of a mark in the sphere of early drug development. But now J&J ($JNJ) is thinking globally and acting locally, creating a plan to become a more prominent player in the field of translational medicine by setting up deal teams in four biotech hotspots around the world. Report